Search

Your search keyword '"Falcão-Pires, Inês"' showing total 408 results

Search Constraints

Start Over You searched for: Author "Falcão-Pires, Inês" Remove constraint Author: "Falcão-Pires, Inês"
408 results on '"Falcão-Pires, Inês"'

Search Results

8. The PERInatal MYocardial Remodeling (PERIMYR) cohort study protocol: A prospective study of cardiac remodeling and “recovery” in pregnancy as a model to understand the impact of comorbidities in cardiac remodeling and reverse remodeling

9. Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function

14. Influence of EPICardial adipose tissue in HEART diseases (EPICHEART) study: Protocol for a translational study in coronary atherosclerosis

15. Stretch-induced compliance mechanism in pregnancy-induced cardiac hypertrophy and the impact of cardiovascular risk factors.

18. Epicardial adipose tissue volume and annexin A2/fetuin-A signalling are linked to coronary calcification in advanced coronary artery disease: Computed tomography and proteomic biomarkers from the EPICHEART study

23. Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction

31. Cardiovascular risk factors during pregnancy impact the postpartum cardiac and vascular reverse remodeling.

33. The PERInatal MYocardial Remodeling (PERIMYR) cohort study protocol:A prospective study of cardiac remodeling and 'recovery' in pregnancy as a model to understand the impact of comorbidities in cardiac remodeling and reverse remodeling

38. Vertical Transmission and Antifungal Susceptibility Profile of Yeast Isolates from the Oral Cavity, Gut, and Breastmilk of Mother–Child Pairs in Early Life

45. MicroRNA-199b is involved in both LV and RV pathological remodeling through distinct molecular mechanisms

46. Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction

48. RF36 | PSUN101 Liver and Adipose Tissue Effects of Triiodothyronine Treatment in an Animal Model of Metabolic Syndrome

49. OR19-2 Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) with Low and High Dose of Triiodothyronine: an Animal Model of Metabolic Syndrome with HFpEF

Catalog

Books, media, physical & digital resources